Assessing Adherence to Antipsychotic Medications

[1]  K. Nuechterlein,et al.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. , 2011, The American journal of psychiatry.

[2]  Martha Sajatovic,et al.  Strategies for Addressing Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations From the Expert Consensus Guidelines , 2010, Journal of psychiatric practice.

[3]  G. Dunn,et al.  A large-scale validation study of the Medication Adherence Rating Scale (MARS) , 2008, Schizophrenia Research.

[4]  A. Rush,et al.  The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder , 2008, Schizophrenia Research.

[5]  M. Byerly,et al.  Antipsychotic medication adherence in schizophrenia. , 2007, The Psychiatric clinics of North America.

[6]  Alexander L. Miller,et al.  Relationships among subjective and objective measures of adherence to oral antipsychotic medications. , 2007, Psychiatric services.

[7]  Thomas J. Carmody,et al.  Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. , 2007, Psychiatric services.

[8]  M. Valenstein,et al.  Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. , 2006, The Journal of clinical psychiatry.

[9]  M. Swartz,et al.  Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. , 2006, The Journal of clinical psychiatry.

[10]  Alexander L. Miller,et al.  Defining and assessing adherence to oral antipsychotics: a review of the literature. , 2005, Schizophrenia bulletin.

[11]  Christian R. Dolder,et al.  Brief Evaluation of Medication Influences and Beliefs: Development and Testing of a Brief Scale for Medication Adherence , 2004, Journal of clinical psychopharmacology.

[12]  Christian R. Dolder,et al.  Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. , 2004, The American journal of psychiatry.

[13]  Christian R. Dolder,et al.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.

[14]  Laurel,et al.  Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission , 2002, Medical care.

[15]  A. Sergejew,et al.  Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses , 2000, Schizophrenia Research.

[16]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[17]  T. Hogan,et al.  A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity , 1983, Psychological Medicine.